System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework
Antimicrobial resistance (AMR) threatens human, animal, and environmental health. Acknowledging the urgency of addressing AMR, an opportunity exists to extend AMR action-focused research beyond the confines of an isolated biomedical paradigm. An AMR learning system, AMR-X, envisions a national netwo...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2024
|
| _version_ | 1811139284530364416 |
|---|---|
| author | Abel, K Agnew, E Amos, J Armstrong, N Armstrong-James, D Ashfield, T Aston, S Baillie, JK Baldwin, S Barlow, G Bartle, V Bielicki, J Brown, C Carrol, E Clements, M Cooke, G Dane, A Dark, P Day, J Eyre, D Hayward, G Pouwels, K Rahman, N Walker, AS |
| author2 | AMR-X Collaborators |
| author_facet | AMR-X Collaborators Abel, K Agnew, E Amos, J Armstrong, N Armstrong-James, D Ashfield, T Aston, S Baillie, JK Baldwin, S Barlow, G Bartle, V Bielicki, J Brown, C Carrol, E Clements, M Cooke, G Dane, A Dark, P Day, J Eyre, D Hayward, G Pouwels, K Rahman, N Walker, AS |
| author_sort | Abel, K |
| collection | OXFORD |
| description | Antimicrobial resistance (AMR) threatens human, animal, and environmental health. Acknowledging the urgency of addressing AMR, an opportunity exists to extend AMR action-focused research beyond the confines of an isolated biomedical paradigm. An AMR learning system, AMR-X, envisions a national network of health systems creating and applying optimal use of antimicrobials on the basis of their data collected from the delivery of routine clinical care. AMR-X integrates traditional AMR discovery, experimental research, and applied research with continuous analysis of pathogens, antimicrobial uses, and clinical outcomes that are routinely disseminated to practitioners, policy makers, patients, and the public to drive changes in practice and outcomes. AMR-X uses connected data-to-action systems to underpin an evaluation framework embedded in routine care, continuously driving implementation of improvements in patient and population health, targeting investment, and incentivising innovation. All stakeholders co-create AMR-X, protecting the public from AMR by adapting to continuously evolving AMR threats and generating the information needed for precision patient and population care. |
| first_indexed | 2024-03-07T08:18:47Z |
| format | Journal article |
| id | oxford-uuid:7a385d80-b522-4acb-ac30-77583b63c9b6 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-09-25T04:03:39Z |
| publishDate | 2024 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:7a385d80-b522-4acb-ac30-77583b63c9b62024-05-10T12:56:56ZSystem-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X frameworkJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7a385d80-b522-4acb-ac30-77583b63c9b6EnglishSymplectic ElementsElsevier2024Abel, KAgnew, EAmos, JArmstrong, NArmstrong-James, DAshfield, TAston, SBaillie, JKBaldwin, SBarlow, GBartle, VBielicki, JBrown, CCarrol, EClements, MCooke, GDane, ADark, PDay, JEyre, DHayward, GPouwels, KRahman, NWalker, ASAMR-X CollaboratorsAntimicrobial resistance (AMR) threatens human, animal, and environmental health. Acknowledging the urgency of addressing AMR, an opportunity exists to extend AMR action-focused research beyond the confines of an isolated biomedical paradigm. An AMR learning system, AMR-X, envisions a national network of health systems creating and applying optimal use of antimicrobials on the basis of their data collected from the delivery of routine clinical care. AMR-X integrates traditional AMR discovery, experimental research, and applied research with continuous analysis of pathogens, antimicrobial uses, and clinical outcomes that are routinely disseminated to practitioners, policy makers, patients, and the public to drive changes in practice and outcomes. AMR-X uses connected data-to-action systems to underpin an evaluation framework embedded in routine care, continuously driving implementation of improvements in patient and population health, targeting investment, and incentivising innovation. All stakeholders co-create AMR-X, protecting the public from AMR by adapting to continuously evolving AMR threats and generating the information needed for precision patient and population care. |
| spellingShingle | Abel, K Agnew, E Amos, J Armstrong, N Armstrong-James, D Ashfield, T Aston, S Baillie, JK Baldwin, S Barlow, G Bartle, V Bielicki, J Brown, C Carrol, E Clements, M Cooke, G Dane, A Dark, P Day, J Eyre, D Hayward, G Pouwels, K Rahman, N Walker, AS System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework |
| title | System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework |
| title_full | System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework |
| title_fullStr | System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework |
| title_full_unstemmed | System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework |
| title_short | System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework |
| title_sort | system wide approaches to antimicrobial therapy and antimicrobial resistance in the uk the amr x framework |
| work_keys_str_mv | AT abelk systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT agnewe systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT amosj systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT armstrongn systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT armstrongjamesd systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT ashfieldt systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT astons systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT bailliejk systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT baldwins systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT barlowg systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT bartlev systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT bielickij systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT brownc systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT carrole systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT clementsm systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT cookeg systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT danea systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT darkp systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT dayj systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT eyred systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT haywardg systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT pouwelsk systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT rahmann systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework AT walkeras systemwideapproachestoantimicrobialtherapyandantimicrobialresistanceintheuktheamrxframework |